Literature DB >> 10196299

Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells.

P Monini1, F Carlini, M Stürzl, P Rimessi, F Superti, M Franco, G Melucci-Vigo, A Cafaro, D Goletti, C Sgadari, S Butto', P Leone, C Chiozzini, C Barresi, A Tinari, A Bonaccorsi, M R Capobianchi, M Giuliani, A di Carlo, M Andreoni, G Rezza, B Ensoli.   

Abstract

Infection by human herpesvirus 8 (HHV-8) is associated with the development of Kaposi's sarcoma (KS). Since regression of KS can be achieved by treatment of the patients with alpha interferon (IFN-alpha), we analyzed the effects of IFN-alpha or anti-IFN-alpha antibodies (Ab) on HHV-8 latently infected primary effusion lymphoma-derived cell lines (BCBL-1 and BC-1) and on peripheral blood mononuclear cells (PBMC) from patients with all forms of KS and from at-risk subjects. IFN-alpha inhibited in a dose-dependent manner the amplification of HHV-8 DNA in BCBL-1 cells induced to lytic infection with tetradecanoyl phorbol acetate (TPA). This effect was associated with the inhibition of the expression of HHV-8 nut-1 and kaposin genes that are induced early and several hours, respectively, after TPA treatment. In addition, IFN-alpha inhibited virus production and/or release from BCBL-1 cells. Inhibition of nut-1 and kaposin genes by IFN-alpha was also observed in BC-1 cells induced with n-butyrate. Conversely, the addition of anti-IFN-alpha Ab to TPA-induced BCBL-1 cells resulted in a larger number of mature enveloped particles and in a more extensive cytopathic effect due to the neutralization of the endogenous IFN produced by these cells. IFN was also produced by cultured PBMC from HHV-8-infected individuals, and this was associated with a loss of viral DNA during culture. However, the addition of anti-IFN-alpha Ab or anti-type I IFN receptor Ab promoted the maintenance of HHV-8 DNA in these cells that was associated with the detection of the latency-associated kaposin RNA. Finally, the addition of IFN-alpha reduced the HHV-8 load in PBMC. Thus, IFN-alpha appears to have inhibitory effects on HHV-8 persistent infection of PBMC. These results suggest that, in addition to inhibiting the expression of angiogenic factors that are key to KS development, IFN-alpha may induce KS regression by reducing the HHV-8 load and/or inhibiting virus reactivation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196299      PMCID: PMC104182     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  87 in total

Review 1.  Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?

Authors:  F Neipel; J C Albrecht; B Fleckenstein
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

2.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.

Authors:  S Uccini; M C Sirianni; L Vincenzi; S Topino; A Stoppacciaro; I Lesnoni La Parola; M Capuano; C Masini; D Cerimele; M Cella; A Lanzavecchia; P Allavena; A Mantovani; C D Baroni; L P Ruco
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

4.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

Authors:  D H Kedes; D Ganem
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

5.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.

Authors:  E Flemington; S H Speck
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?

Authors:  V Fiorelli; R Gendelman; M C Sirianni; H K Chang; S Colombini; P D Markham; P Monini; J Sonnabend; A Pintus; R C Gallo; B Ensoli
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

8.  Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma.

Authors:  E Tur; S Brenner; R Michalevicz
Journal:  Arch Dermatol       Date:  1993-10

9.  A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.

Authors:  M Schalling; M Ekman; E E Kaaya; A Linde; P Biberfeld
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

10.  Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells.

Authors:  F Oberman; A Panet
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

View more
  22 in total

1.  Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.

Authors:  B Lubyova; P M Pitha
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  P Rimessi; A Bonaccorsi; M Stürzl; M Fabris; E Brocca-Cofano; A Caputo; G Melucci-Vigo; M Falchi; A Cafaro; E Cassai; B Ensoli; P Monini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.

Authors:  Francesco Broccolo; Simona Bossolasco; Anna M Careddu; Giuseppe Tambussi; Adriano Lazzarin; Paola Cinque
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

6.  Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency.

Authors:  Erik S Barton; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Interferon Regulatory Factor 1 and Type I Interferon Cooperate To Control Acute Gammaherpesvirus Infection.

Authors:  Wadzanai P Mboko; Michaela M Rekow; Mitchell P Ledwith; Philip T Lange; Kaitlin E Schmitz; Sean Anderson; Vera L Tarakanova
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

8.  Modulation of human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus replication and transcription activator transactivation by interferon regulatory factor 7.

Authors:  Jinzhong Wang; Jun Zhang; Luwen Zhang; William Harrington; John T West; Charles Wood
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

9.  Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages.

Authors:  Brittani M Wood; Wadzanai P Mboko; Bryan C Mounce; Vera L Tarakanova
Journal:  Virology       Date:  2013-05-23       Impact factor: 3.616

Review 10.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.